company background image
BMT

Beamtree HoldingsASX:BMT Stock Report

Market Cap

AU$142.9m

7D

4.5%

1Y

88.7%

Updated

25 Oct, 2021

Data

Company Financials +
BMT fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BMT Overview

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for Beamtree Holdings
Historical stock prices
Current Share PriceAU$0.58
52 Week HighAU$0.28
52 Week LowAU$0.70
Beta1.8
1 Month Change12.50%
3 Month Change31.46%
1 Year Change88.71%
3 Year Changen/a
5 Year Changen/a
Change since IPO225.00%

Recent News & Updates

Shareholder Returns

BMTAU Healthcare ServicesAU Market
7D4.5%1.5%0.6%
1Y88.7%42.9%21.3%

Return vs Industry: BMT exceeded the Australian Healthcare Services industry which returned 42.9% over the past year.

Return vs Market: BMT exceeded the Australian Market which returned 21.3% over the past year.

Price Volatility

Is BMT's price volatile compared to industry and market?
BMT volatility
BMT Beta1.8
Industry Beta0.49
Market Beta1

Stable Share Price: BMT is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: BMT's weekly volatility (11%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aTim Kelseyhttps://beamtree.com.au

Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, a solution that audit data in real-time in pathology, including data entry, billing, and specimen reception; and PICQ, a coding quality tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference for clinical coding patient records.

Beamtree Holdings Fundamentals Summary

How do Beamtree Holdings's earnings and revenue compare to its market cap?
BMT fundamental statistics
Market CapAU$142.88m
Earnings (TTM)-AU$383.62k
Revenue (TTM)AU$8.39m

17.0x

P/S Ratio

-372.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BMT income statement (TTM)
RevenueAU$8.39m
Cost of RevenueAU$5.62m
Gross ProfitAU$2.77m
ExpensesAU$3.15m
Earnings-AU$383.62k

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.0016
Gross Margin32.98%
Net Profit Margin-4.57%
Debt/Equity Ratio0%

How did BMT perform over the long term?

See historical performance and comparison

Valuation

Is Beamtree Holdings undervalued compared to its fair value and its price relative to the market?

3.39x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate BMT's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate BMT's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: BMT is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: BMT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate BMT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: BMT is good value based on its PB Ratio (3.4x) compared to the AU Healthcare Services industry average (4.2x).


Future Growth

How is Beamtree Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

140.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BMT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: BMT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: BMT's is expected to become profitable in the next 3 years.

Revenue vs Market: BMT's revenue (46% per year) is forecast to grow faster than the Australian market (5.3% per year).

High Growth Revenue: BMT's revenue (46% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BMT's Return on Equity is forecast to be low in 3 years time (9%).


Past Performance

How has Beamtree Holdings performed over the past 5 years?

-76.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BMT is currently unprofitable.

Growing Profit Margin: BMT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BMT is unprofitable, and losses have increased over the past 5 years at a rate of 76.7% per year.

Accelerating Growth: Unable to compare BMT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BMT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (37.7%).


Return on Equity

High ROE: BMT has a negative Return on Equity (-0.91%), as it is currently unprofitable.


Financial Health

How is Beamtree Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: BMT's short term assets (A$17.4M) exceed its short term liabilities (A$3.8M).

Long Term Liabilities: BMT's short term assets (A$17.4M) exceed its long term liabilities (A$1.2M).


Debt to Equity History and Analysis

Debt Level: BMT is debt free.

Reducing Debt: BMT has not had any debt for past 5 years.

Debt Coverage: BMT has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: BMT has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Beamtree Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BMT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BMT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BMT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BMT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BMT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

0.6yrs

Average management tenure


CEO

Tim Kelsey

1

Tenure

AU$735,477

Compensation

Mr. Tim Kelsey has been Commercial Director at Telstra Health since July 1, 2016. Mr. Kelsey serves as the Chief Executive Officer at Beamtree Holdings Limited (formerly known as PKS Holdings Limited) sinc...


CEO Compensation Analysis

Compensation vs Market: Tim's total compensation ($USD551.33K) is above average for companies of similar size in the Australian market ($USD302.38K).

Compensation vs Earnings: Insufficient data to compare Tim's compensation with company performance.


Leadership Team

Experienced Management: BMT's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.


Board Members

Experienced Board: BMT's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: BMT insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.4%.


Top Shareholders

Company Information

Beamtree Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Beamtree Holdings Limited
  • Ticker: BMT
  • Exchange: ASX
  • Founded: 1996
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$142.878m
  • Shares outstanding: 244.24m
  • Website: https://beamtree.com.au

Number of Employees


Location

  • Beamtree Holdings Limited
  • 16 Eveleigh Street
  • Redfern
  • New South Wales
  • 2016
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 16:59
End of Day Share Price2021/10/25 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.